RetractedArticleBioscience reports2019

MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway.

Liwei Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.